Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene-related peptide (CGRP) receptor. Erenumab prevents the increase in dermal blood flow in cynomolgus monkeys. Erenumab can be used in the research of episodic migraine[1][2][3].
Molecular Weight:
(145.5 kDa)
Purity:
98.88
CAS Number:
[1582205-90-0]
Target:
CGRP Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted